Institutional Ownership
Tarsus Pharmaceuticals Inc
CUSIP 87650L103COMTARSQ1 2026
13D / 13G Filings
54
Schedule 13D/13G on record
Beneficial Filers
24
Distinct reporting persons
Largest Stake
16.2%
Max % of class reported
Institutional Holders
246
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
54 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Tang Capital Management, LLC | 13G/A | 2.8% | 1.19M | SEC |
| 2 | Nov 14, 2025 | Deep Track Capital, LP | 13G/A | 7.1% | 3.00M | SEC |
| 3 | Aug 14, 2025 | Rtw Investments, LP | 13G/A | 8.1% | 3.42M | SEC |
| 4 | Jul 28, 2025 | Deep Track Capital, LP | 13G | 5.6% | 2.35M | SEC |
| 5 | May 15, 2025 | Tang Capital Management, LLC | 13G/A | 5.9% | 2.45M | SEC |
| 6 | May 7, 2025 | Morgan Stanley | 13G/A | 4.7% | 1.94M | SEC |
| 7 | Apr 24, 2025 | Blackrock, Inc. | 13G/A | 7.4% | 3.09M | SEC |
| 8 | Feb 13, 2025 | Cowen Financial Products LLC | 13G/A | 4.9% | 1.91M | SEC |
| 9 | Nov 14, 2024 | Cormorant Asset Management, LP | 13G/A | 1.3% | 500.0K | SEC |
| 10 | Nov 14, 2024 | Prudential Financial Inc | 13G | 6.0% | 2.30M | SEC |
44 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Tarsus Pharmaceuticals Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Deep Track Capital, LP | 3.60M | $252.54M |
| 2 | Blackrock, Inc. | 3.55M | $249.22M |
| 3 | Rtw Investments, LP | 3.35M | $234.72M |
| 4 | Paradigm Biocapital Advisors LP | 2.56M | $179.74M |
| 5 | Janus Henderson Group PLC | 2.24M | $157.22M |
| 6 | Morgan Stanley | 1.94M | $136.39M |
| 7 | Jennison Associates LLC | 1.71M | $120.11M |
| 8 | Assenagon Asset Management S.A. | 1.28M | $89.81M |
| 9 | Bank Of America Corp /De/ | 1.19M | $83.79M |
| 10 | Tang Capital Management LLC | 1.19M | $83.38M |